HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yifei Lu Selected Research

pectenotoxin-8

10/2017Tumor-Targeting Micelles Based on Linear-Dendritic PEG-PTX8 Conjugate for Triple Negative Breast Cancer Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yifei Lu Research Topics

Disease

34Neoplasms (Cancer)
01/2022 - 01/2015
6Glioma (Gliomas)
01/2018 - 01/2015
5Inflammation (Inflammations)
10/2021 - 07/2019
5Triple Negative Breast Neoplasms
11/2019 - 10/2017
4Breast Neoplasms (Breast Cancer)
01/2019 - 01/2017
3Metabolic Diseases (Metabolic Disease)
11/2020 - 01/2020
2Diabetic Retinopathy (Retinopathy, Diabetic)
05/2022 - 04/2020
2Hypertension (High Blood Pressure)
09/2021 - 01/2020
2Hyperplasia
08/2020 - 01/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2020 - 05/2018
2Nervous System Diseases (Neurological Disorders)
01/2020 - 04/2017
2Alzheimer Disease (Alzheimer's Disease)
01/2020 - 02/2019
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2017 - 08/2016
1Lung Injury
03/2022
1Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2022
1Fibrosis (Cirrhosis)
03/2022
1Myocardial Infarction
03/2022
1Disease Resistance
01/2022
1Bites and Stings (Sting)
01/2022
1Insulin Resistance
12/2021
1Cognitive Dysfunction
12/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2021
1Dyslipidemias (Dyslipidemia)
10/2021
1Wounds and Injuries (Trauma)
10/2021
1Acute Retinal Necrosis Syndrome
06/2021
1Necrosis
06/2021
1Pneumonia (Pneumonitis)
04/2021
1Abscess
01/2021

Drug/Important Bio-Agent (IBA)

10Pharmaceutical PreparationsIBA
07/2019 - 01/2016
8MicellesIBA
05/2019 - 03/2015
6Therapeutic UsesIBA
03/2022 - 01/2018
6Peptides (Polypeptides)IBA
09/2021 - 01/2016
5ProdrugsIBA
03/2019 - 01/2018
4CytokinesIBA
10/2021 - 11/2018
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 04/2017
4Proteins (Proteins, Gene)FDA Link
09/2021 - 11/2018
4MicroRNAs (MicroRNA)IBA
01/2021 - 07/2019
4Paclitaxel (Taxol)FDA LinkGeneric
12/2019 - 10/2017
3Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2017
3Amino AcidsFDA Link
01/2020 - 10/2016
3AcidsIBA
11/2019 - 01/2017
3LigandsIBA
07/2019 - 01/2018
3PolymersIBA
07/2019 - 04/2017
3Glutathione (Reduced Glutathione)IBA
07/2019 - 01/2015
3Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
07/2019 - 03/2015
3PlatinumIBA
03/2019 - 10/2017
2Fluorescein (Funduscein)FDA LinkGeneric
05/2022 - 04/2020
2Biological ProductsIBA
03/2022 - 10/2017
2AntigensIBA
01/2022 - 04/2019
2LipidsIBA
10/2021 - 01/2020
2Retinaldehyde (Retinal)IBA
06/2021 - 04/2020
2EnzymesIBA
01/2021 - 02/2020
2kaempferolIBA
01/2021 - 11/2020
2APTIBA
11/2019 - 05/2018
2TenascinIBA
11/2019 - 05/2018
2Dehydroascorbic AcidIBA
07/2019 - 03/2015
2polyethylene glycol-poly(lactide-co-glycolide)IBA
11/2018 - 10/2016
24,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
11/2018 - 10/2016
2Substance PIBA
01/2018 - 10/2017
2Adenosine Triphosphate (ATP)IBA
01/2017 - 10/2016
1Carotenoids (Carotene)IBA
03/2022
1TocotrienolsIBA
03/2022
1Bleomycin (Blenoxane)FDA LinkGeneric
03/2022
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
03/2022
1Antimicrobial PeptidesIBA
01/2022
1Biopolymers (Biopolymer)IBA
01/2022
1InterferonsIBA
01/2022
1NucleotidesIBA
01/2022
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2022
1Adenosine Monophosphate (AMP)IBA
01/2022
1Guanosine Monophosphate (5' Guanylic Acid)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
12/2021
1Insulin (Novolin)FDA Link
12/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2021
1Thiamine (Aneurin)FDA Link
12/2021
1Plant Oils (Vegetable Oils)IBA
12/2021
1Vitamin A (Retinol)FDA LinkGeneric
11/2021
1Linseed Oil (Flaxseed Oil)IBA
10/2021
1Apolipoproteins B (ApoB)IBA
10/2021
1Apolipoproteins AIBA
10/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021
1LignansIBA
10/2021
1oxidized low density lipoproteinIBA
10/2021
1C-Reactive ProteinIBA
10/2021
1ChemokinesIBA
10/2021
1Heparin (Liquaemin)FDA LinkGeneric
10/2021
1HydrogelsIBA
10/2021
1Vitamin DFDA LinkGeneric
04/2021
1Anti-Bacterial Agents (Antibiotics)IBA
04/2021
1hydroxide ionIBA
04/2021
1Tumor Biomarkers (Tumor Markers)IBA
01/2021
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2021
1endolysinIBA
01/2021
1osteoblast cadherinIBA
01/2021

Therapy/Procedure

21Therapeutics
03/2022 - 01/2015
8Drug Therapy (Chemotherapy)
08/2020 - 01/2016
3Immunotherapy
01/2022 - 01/2018
2Nanospheres
07/2019 - 01/2015
1Microbubbles
01/2022